AAA disease: Mechanism, stratification, and treatment

Annals of the New York Academy of Sciences

Volumn 1085, Issue , 2006, Pages 92-109

  Dalman, Ronald L ^a,d   Tedesco, Maureen M ^a   Myers, Jonathon ^b   Taylor, Charles A ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Palo Alto Veterans Institute for Research   (United States)

^c Stanford University   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abdominal aortic aneurysm; Exercise; Hemodynamics

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; ANEURYSM SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; EXERCISE; HEMODYNAMICS; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ANIMAL; ARTICLE; BLOOD FLOW; PATHOLOGY; RISK FACTOR; THREE DIMENSIONAL IMAGING;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 34447619154     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1383.008     Document Type: Conference Paper

References (100)

1. LEDERLE, F.A., G.R. JOHNSON, S.E. WILSON, et al. 2000. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch. Intern. Med. 160: 1425-1430.
2. ASHTON, H.A., M.J. BUXTON, N.E. DAY, et al. 2002. Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomized controlled trial. Lancet 360: 1531-1539.
3. LAWRENCE-BROWN, M.M., P.E. NORMAN, K. JAMROZIK, et al. 2001. Initial results of ultrasound screening for aneurysm of the abdominal aorta in Western Australia: relevance for endoluminal treatment of aneurysm disease. Cardiovasc. Surg. 9: 234-240.
4. WILMINK, T.B. & C.R. QUICK. 1998. Epidemiology and potential for prevention of abdominal aortic aneurysm. Br. J. Surg. 85: 155-162.
5. WILMINK, T.B., C.R. QUICK, C.S. HUBBARD, et al. 1999. The influence of screening on the incidence of ruptured abdominal aortic aneurysms. J. Vasc. Surg. 30: 203-208.
6. LINDHOLT, J.S., S. JUUL, H. FASTING, et al. 2002. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from a randomized population screening trial. Eur. J. Vasc. Endovasc. Surg. 23: 55-60.
7. KENT, K.C., R.M. ZWOLAK, M.R. JAFF, et al. 2004. Screening for abdominal aortic aneurysm: a consensus statement. J. Vasc. Surg. 39: 267-269.
8. BREWSTER, D.C., J.L. CRONENWETT, J.W. HALLETT, et al. 2003. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J. Vasc. Surg. 37: 1106-1117.
9. WILMINK, A.B., M. FORSHAW, C.R. QUICK, et al. 2002. Accuracy of serial screening for abdominal aortic aneurysms by ultrasound. J. Med. Screen 9: 125-127.
10. WILMINK, A.B., C.S. HUBBARD & C.R. QUICK. 1997. Quality of the measurement of the infrarenal aortic diameter by ultrasound. J. Med. Screen 4: 49-53.
11. WASSEF, M., B.T. BAXTER, R. CHISHOLM, et al. 2001. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung and Blood Institute. J. Vasc. Surg. 34: 730-738.
12. FILLINGER, M.F., M.L. RAGHAVAN, S.P. MARRA, et al. 2002. In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J. Vasc. Surg. 36: 589-597.
13. LEDERLE, F.A., G.R. JOHNSON, S.E. WILSON, et al. 2002. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 287: 2968-2972.
14. BRADY, A.R., S.G. THOMPSON, R.M. GREENHALGH & J.T. POWELL, FOR THE UK SMALL ANEURYSM TRIAL PARTICIPANTS. 2003. Cardiovascular risk factors and abdominal aortic aneurysm expansion: only smoking counts. Br. J. Surg. 90: 491-492.
15. HELLER, J.A., A. WEINBERG, R. ARONS, et al. 2000. Two decades of abdominal aortic aneurysm repair: have we made any progress? J. Vasc. Surg. 32: 1091-1100.
16. FLEMING, C., E.P. WHITLOCK, T.L. BELL, et al. 2005. Screening for abdominal aortic aneurysm: a best-evidence systemic review for the U. S. Preventative Services Task Force. Ann. Intern. Med. 142: 203-211.
17. DAUGHERTY, A. & L.A. CASSIS. 2004. Mouse models of abdominal aortic aneurysm disease. Arteriosclero. Thromb. Vasc. Biol. 24: 1-6.
18. PETRINEC, D., S. LIAO, D.R. HOLMES, et al. 1996. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm; preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg. 23: 336-346.
19. BIGATEL, D.A., J.R. ELMORE, D.J. CAREY, et al. 1999. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J. Vasc. Surg. 29: 130-138.
20. LIAO, S., M. MIRALLES, B.J. KELLEY, et al. 2001. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J. Vasc. Surg. 33: 1057-1064.
21. NAKASHIMA, H., M. AOKI, T. MIYAKE, et al. 2004. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and its transcription factors. Circulation 109: 132-138.
22. LAWRENCE, D.M., R.S. SINGH, D.P. FRANKLIN, et al. 2004. Rapamycin suppresses experimental aneurysm growth. J. Vasc. Surg. 40: 334-338.
23. NAGASHIMA, H., Y. AOKA, Y. SAKOMURA, et al. 2002. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in the human abdominal aortic aneurysm wall. J. Vasc. Surg. 36: 158-163.
24. STEINMETZ, E.F., C. BUCKLEY, M. SHAMES, et al. 2005. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann. Surg. 241: 92-101.
25. DALMAN, R.L. 2006. Vitamin E limits AAA. Arterioscler. Thromb. Vasc. Biol. 26: e21.
26. BRUEMMER, D., A.R. COLLINS, G. NOH, et al. 2003. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J. Clin. Invest. 112: 1318-1331.
27. SHO, E., M. SHO, K. HOSHINA, et al. 2004. Hemodynamic forces regulate mural macrophage infiltration in experimental aortic aneurysms. Exp. Mol. Pathol. 76: 108-116.
28. + cell localization and differentiation in experimental aneurysms. Arteriosclero. Thomb. Vasc. Biol. 24: 1916-1921.
29. HOSHINA, K., H. KOYAMA, T. MIYATA, et al. 2004. Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental aortic aneurysm. J. Vasc. Surg. 40: 512-518.
30. POWELL, J.T. & A.R. BRADY. 2004. Detection, management and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler. Thomb. Vasc. Biol. 24: 241-245.
31. BAXTER, B.T., W.H. PEARCE, E.A. WALTKE, et al. 2002. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (phase II) multicenter study. J. Vasc. Surg. 36: 1-12.
32. TAYLOR, C.A., T.J. HUGHES & C.K. ZARINS. 1999. Effects of exercise on hemodynamic conditions in the abdominal aorta. J. Vasc. Surg. 29: 1077-1089.
33. ALIWADI, G., B.S. KNIPP, G. LU, et al. 2003. A non-intrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J. Vasc. Surg. 37: 1059-1066.
34. VOLLMAR, J.F., F. PAES, P. PAUSCHINGER, et al. 1989. Aortic aneurysms as late sequela of above knee amputation. Lancet 7: 834-835.
35. GORDON, I.L., C.A. KOHL, M. AREFI, et al. 1996. Spinal cord injury increases the risk of abdominal aortic aneurysm. Am. Surg. 62: 249-252.
36. SANDGREN, T., B. SONESSON, A.R. AHLGREN, et al. 2001. Arterial dimensions in the lower extremities of patients with abdominal aortic aneurysm disease: no evidence of a generalizing dilating diathesis. J. Vasc. Surg. 34: 730-738.
37. GIMBRONE, M.A., JR., K.R. ANDERSON, J.N. TOPPER, et al. 1999. Special communication: the critical role of mechanical forces in blood vessel development, physiology and pathology. J. Vasc. Surg. 29: 1104-1151.
38. KUNSCH, C. & R.M. MEDFORD. 1999. Oxidative stress as a regulator of gene expression. Circ. Res. 82: 753-766.
39. BERK, B.C. 1999. Redox signals that regulate the vascular response to injury. Thromb. Haemost. 82: 753-766.
40. MCMILLAN, W.D. & W.H. PEARCE. 1999. Increased levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J. Vasc. Surg. 29: 122-127.
41. PYO, R., J.K. LEE, J.M. SHIPLEY, et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649.
42. PARKS, W.C. 2002. A confederacy of proteinases. J. Clin. Invest. 110: 613-614.
43. LUM, H. & K.A. ROEBUCK. 2001. Oxidant stress and endothelial cell dysfunction. Am. J. Physiol. Cell. Physiol. 280: C719-C741.
44. DE KEULENAER, G.W., R.W. ALEXANDER, M. USHIO-FUKAI, et al. 1998. Oscillatory and steady laminar shear stress differentially effect human endothelial redox state: the role of a superoxide-producing NADH oxidase. Circ. Res. 82: 1094-1101.
45. MASUDA, H., Y.J. ZHUANG, T.M. SINGH, et al. 1999. Adaptive remodeling on internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arteriosclero. Thromb. Vasc. Biol. 19: 2298-2307.
46. TOBIASCH, E., I. GUNTHER & F.H. BACH. 2001. Heme oxygenase protects pancreatic beta cells from apoptosis caused by various stimuli. J. Invest. Med. 49: 566-571.
47. TULIS, D.A., W. DURANTE, X. LIU, et al. 2001. Adenovirus-mediated hemeoxygenase gene delivery inhibits injury-induced vascular neointimal formation. Circulation 104: 2710-2715.
48. SUTTNER, D.M. & P.A. DENNERY. 1999. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 13: 1800-1808.
49. SCHILLINGER, M., M. EXNER, W. MIEKUSCH, et al. 2002. Heme oxygenase 1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb. Res. 106: 131-136.
50. NAKAHASHI, T.K., K. HOSHINA, P.S. TSAO, et al. 2002. Flow loading induces macrophage antioxidative gene expression in experimental aneurysms. Arterioscler. Thromb. Vasc. Biol. 22: 2017-2022.
51. MILLER, F.J., JR. 2002. Aortic aneurysms: It's all about the stress. Arteriosclero. Thromb. Vasc. Biol. 22: 1948-1949.
52. TAYLOR, C.A., C.P. CHENG, L.A. ESPINOSA, et al. 2002. In vivo quantification of blood flow and wall shear stress in the human abdominal aorta during lower limb exercise. Ann. Biomed. Eng. 30: 402-408.
53. CHENG, C.P., R.J. HERFKENS & C.A. TAYLOR. 2003. Comparison of abdominal aortic hemodynamics between men and women at rest and during lower limb exercise. J. Vasc. Surg. 37: 118-123.
54. CHENG, C.P., R.J. HERFKENS & C.A. TAYLOR. 2003. Abdominal aortic hemodynamic conditions in healthy subjects aged 50-70 at rest and during lower limb exercise: in vivo quantification using MRI. Atherosclerosis 168: 223-231.
55. LEDERLE, F.A., G.R. JOHNSON, S.E. WILSON, et al. FOR THE ADAM VA CSP PROGRAM. 2003. Quality of life, impotence, and activity level in a randomized trial of immediate repair vs. surveillance of small abdominal aortic aneurysms. J. Vasc. Surg. 38: 745-752.
56. MYERS, J., M. PRAKASH, V. FROELICHER, et al. 2002. Exercise capacity and mortality among men referred for exercise testing. N. Engl. J. Med. 346: 793-801.
57. LEDERLE, F.A., G.R. JOHNSON, S.E. WILSON, et al. 1997. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann. Intern. Med. 15: 441-449.
58. YEUNG, J.J., H.J. KIM, T.A. ABBRUZZESE, et al. 2006. Aortoiliac hemodynamic and morphologic adaptation to chronic spinal cord injury. J. Vasc. Surg. In press.
59. TAYLOR, C.A., C.P. CHENG, L.A. ESPINOSA, et al. 2002. In vivo quantification of blood flow and wall shear stress in the human abdominal aorta during lower limb exercise. Ann. Biomed. Eng. 30: 402-408.
60. CHENG, C.P., D.F. SCHWANDT, E.L. TOPP, et al. 2003. Dynamic exercise imaging with an MR-compatible stationary cycle within the general electric open magnet. Magn. Reson. Med. 49: 581-585.
61. PELC, N.J., M.A. BERNSTEIN, A. SHIMAKAWA, et al. 1991. Encoding strategies for three-direction phase-contrast MR imaging of flow. J. Magn. Reson. Imaging 1: 405-413.
62. PELC, N.J., R.J. HERFKENS, A. SHIMAKAWA, et al. 1991. Phase contrast cine magnetic resonance imaging. Magn. Reson. Q. 7: 229-254.
63. PELC, N.J., F.G. SOMMER, K.C. LI, et al. 1994. Quantitative magnetic resonance flow imaging. Magn. Reson. Q. 10: 125-147.
64. WANG, K., R. DUTTON & C.A. TAYLOR. 1999. Geometric image segmentation and image-based model construction for computational hemodynamics. IEEE Eng. Med. Biol. 18: 33-39.
65. WANG, K.C. 2001. Level set methods for computational prototyping with application to hemodynamic modeling. Department of Electrical Engineering, Stanford University, Stanford, CA.
66. CHENG, C.P., D. PARKER & C.A. TAYLOR. 2002. Quantification of wall shear stress in large blood vessels using Lagrangian interpolation functions with cine phase-contrast magnetic resonance imaging. Ann. Biomed. Eng. 30: 1020-1032.
67. HE, X. & D. KU. 1996. Pulsatile flow in the human left coronary artery bifurcation: average conditions. J. Biomech. Eng. 118: 74-82.
68. SASSUK, S.S. & J.E. MANSON. 2003. Physical activity and the prevention of cardiovascular disease. Curr. Athero. Reports 5: 299-307.
69. REHMAN, J., J. LI, L. PARVATHANENI, et al. 2004. Exercise acutely increases circulation progenitor cells and monocyte-macrophage-derived angiogenic cells. J. Am. Coll. Cardiol. 43: 2314-2318.
70. GREEN, D., A. MAIORANA, G. O'DRISCOLL, et al. Effect of exercise training on endothelium-derived nitric oxide function in humans. J. Physiol. (London) 9/16/04, epub ahead of print.
71. TAYLOR, C.A., T.J.R. HUGHES & C.K. ZARINS. 1996. Computational investigations in vascular disease. Comp. Phys. 10: 224-232.
72. TAYLOR, C.A., T.J.R. HUGHES & C.K. ZARINS. 1998. Finite element modeling of blood flow in arteries. Comp. Meth. Appl. Mech. Eng. 158: 155-196.
73. TAYLOR, C.A., T.J.R. HUGHES, C.K. ZARINS. 1998. Finite element modeling of three-dimensional pulsatile flowin the abdominal aorta: relevance to atherosclerosis. Ann. Biomed. Eng. 26: 1-14.
74. TAYLOR, C.A., M.T. DRANEY, J.P. KU, et al. 1999. Predictive medicine: computation techniques in therapeutic decision-making. Comp. Aided Surg. 4: 231-247.
75. KU, J.P., M.T. DRANEY, F.R. ARKO, et al. 2002. In vivo validation of numerical predications of blood flow in arterial bypass grafts. Ann. Biomed. Eng. 30: 743-752.
76. KU, J.P., C.J. ELKINS & C.A. TAYLOR. 2005. Comparison of CFD and MRI flow and velocities in an in vitro large artery bypass graft model. Ann. Biomed. Eng. 33: 257-269.
77. WANG, K. 1998. Level set methods and MR image segmentation for geometric modeling in computational hemodynamics. Presented at the IEEE Biomedical Engineering in Medicine and Biology Society. Hong Kong, China.
78. WILSON, N.M., R. DUTTON & C.A. TAYLOR. 2001. A software framework for creating patient specific geometric models from medical imaging data for simulation-based medical planning of vascular surgery. Lecture Notes Comp. Sci. 2208: 449-456.
79. WILSON, N.M. Geometric algorithms and software architecture for computational prototyping: applications in vascular surgery and MEMS. In Mechanical Engineering 2002. Stanford University, Stanford, CA.
80. TAYLOR, C.A. 1997. Finite element analysis of pulsatile flow in the human abdominal aorta: geometric model construction from spiral CT data. Presented at ASME Bioengineering. Sunriver, OR.
81. WAN, J., B.N. STEELE, S.A. SPICER, et al. 2002. One-dimensional finite element method for simulation-based medical planning for cardiovascular disease. Comp. Meth. Biomech. Biomed. Engin. 5: 195-206.
82. STEELE, B.N., J. WAN, J.P. KU, et al. 2003. In vivo validation of a one-dimensional finite element method for simulation-based medical planning for cardiovascular bypass surgery. IEEE Trans. Biomed. Engin. 50: 649-656.
83. VIGNON, I. & C.A. TAYLOR. 2004. Outflow boundary conditions for one-dimensional finite element modeling of blood flow and pressure waves in arteries. Wave Motion 39: 361-374.
84. OLUFSEN, M.S. 1999. A structured tree outflow condition for blood flow in the larger systemic arteries. Am. J. Physiol. 267: H257-H268.
85. SCHUTZ, Y., S. WEINSIER, P. TERRIER, et al. 2002. A new accelerometric method to assess the daily walking practice. Int. J. Obes. Relat. Metab. Disord. 26: 111-118.
86. FROELICHER, V.F., D. JENSEN, F. GENTER, et al. 1984. A randomized trial of exercise training in patients with coronary heart disease. JAMA 252: 1291-1297.
87. TAYLOR, R.S., A. BROWN, S. EBRAHIM, et al. 2004. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trails. Am. J. Med. 16: 682-692.
88. THOMPSON, P.D. 2002. Additional steps for cardiovascular health. NEJM 347: 755-756.
89. MYERS, J., A. KAYKHA, S. GEORGE, et al. 2004. Fitness versus physical activity patterns in predicting mortality in men. Am. J. Med. 117: 912-918.
90. WEISS, J.P., V.F. FROELICHER, J. MYERS, et al. 2004. Health-care costs and exercise capacity. Chest 126: 608-613.
91. POWELL, J.T., B.R. MULLER & R.M. GREENHALGH. 1987. Acute phase proteins in patients with abdominal aortic aneurysm disease. J. Cardiovasc. Surg. 28: 528-530.
92. NORMAN, P., C.A. SPENCER, M.M. LAWRENCE- BROWN, et al. 2004. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 110: 862-866.
93. VAINAS, T., T. LUBBERS, F.R.M. STASSEN, et al. 2003. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107: 1103-1105.
94. FORD, E.S. 2002. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 13: 561-568.
95. GEFFKEN, D.F., M. CUSHMAN, G.L. BURKE, et al. 2001. Association between physical activity and markers on inflammation in an elderly health population. Am. J. Epidemiol. 153: 242-250.
96. ZHANG, J., J. SCHMIDT, E. RYSCHICH, et al. 2003. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38: 360-367.
97. ARMSTRONG, P.J., D.P. FRANKLIN, D.J. CAREY, et al. 2005. Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. Ann. Vasc. Surg. 19(2): 248-257.
98. JOHANNING, J.M., P.J. ARMSTRONG, D.P. FRANKLIN, et al. 2002. Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition. Ann. Vasc. Surg. 16: 65-72.
99. YANG, A.L. & H.I. CHEN. 2003. Chronic exercise reduces adhesion molecules/iNOS expression and partially reverses vascular responsiveness in hypercholesterolemic rabbit aortae. Atherosclerosis 169: 11-17.
100. GIELEN, S., V. ADAMS, S. MOBIUS-W INKLER, et al. 2003. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J. Am. Coll. Cardiol. 42: 861-868.